Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 154 (CCDC154) is a protein encoded by the CCDC154 gene, predicted to play a role in bone mineralization and maturation, bone resorption, odontogenesis, and sensory perception of sound[1][8]. The protein features a coiled-coil structural motif and is implicated in the suppression of cell proliferation by inducing G2/M cell cycle arrest[5][6]. CCDC154 interacts with proteins involved in the cell cycle, such as minichromosome maintenance complex component 2 (MCM2), and has been implicated in the promotion of colorectal cancer proliferation and metastasis[2]. High expression of CCDC154 has been shown to correlate with poorer survival in colorectal cancer and changes in immune cell infiltration, indicating its role as a potential prognostic biomarker in oncology[2]. It has also been associated with rare genetic disorders like osteopetrosis and mucolipidosis III gamma[1][8][5][6]. No approved drugs are known to directly target this protein, and it is not currently considered a classic therapeutic target (e.g., receptor, enzyme, transporter)[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 154 (CCDC154).